China has signed intellectual property (IP) cooperation agreements with 57 Belt and Road Initiative (BRI) partner countries, further strengthening bilateral cooperation, according to the China National Intellectual Property Administration (CNIPA).
After a decade of fierce legal battles, Mindray has suffered a significant defeat against its emerging rival, Comen. In late August, the China National Intellectual Property Administration declared Mindray’s utility model patent completely invalid due to a lack of inventiveness.
DT Mobile and Samsung have resolved their patent disputes involving claims totaling RMB 123 million, according to an announcement made on August 29 by CICT Mobile, DT Mobile’s parent company. The settlement covers six patent infringement cases filed by DT Mobile against Samsung.
Chinese medical device maker Fulbright Medical Inc.’s plans to list on the Shanghai Stock Exchange (SSE) have been thwarted due to extensive patent litigation. The company's IPO application, which was accepted on June 30, 2023, has now been officially terminated.
Since June 30, 2023, Sekisui Chemical has lodged five separate patent infringement lawsuits against Zhejiang Decent New Material, seeking a total of over 116 million yuan in damages. The lawsuits pertain to five Chinese invention patents related to laminated glass.
